Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites

Cell Host and Microbe

Volumn 9, Issue 6, 2011, Pages 451-462

  Butler, Noah S ^a   Schmidt, Nathan W ^a   Vaughan, Ashley M ^b   Aly, Ahmed S ^b   Kappe, Stefan H I ^b,c   Harty, John T ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETICALLY ATTENUATED PARASITE VACCINE; MALARIA VACCINE; RADIATION ATTENUATED SPOROZOITE VACCINE; SPOROZOITE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA MODIFICATION; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENE DELETION; HUMANS; LIVER; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PLASMODIUM YOELII; SPOROZOITES; VACCINATION; VACCINES, ATTENUATED;

MUS;

EID: 79958717556     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2011.05.008     Document Type: Article

References (56)

1. Aide, P., Aponte, J.J., Renom, M., Nhampossa, T., Sacarlal, J., Mandomando, I., Bassat, Q., Manaca, M.N., Leach, A., Lievens, M., et al. (2010). Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial. PLoS ONE 5, e13838.
2. Aly, A.S., Mikolajczak, S.A., Rivera, H.S., Camargo, N., Jacobs-Lorena, V., Labaied, M., Coppens, I., and Kappe, S.H. (2008). Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Mol. Microbiol. 69, 152-163.
3. Belnoue, E., Voza, T., Costa, F.T., Grüner, A.C., Mauduit, M., Rosa, D.S., Depinay, N., Kayibanda, M., Vigário, A.M., Mazier, D., et al. (2008). Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 181, 8552-8558.
4. Berenzon, D., Schwenk, R.J., Letellier, L., Guebre-Xabier, M., Williams, J., and Krzych, U. (2003). Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J. Immunol. 171, 2024-2034. (Pubitemid 36969799)
5. Butler, N.S., Schmidt, N.W., and Harty, J.T. (2010). Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J. Immunol. 184, 2528-2538.
6. Chakravarty, S., Cockburn, I.A., Kuk, S., Overstreet, M.G., Sacci, J.B., and Zavala, F. (2007). CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13, 1035-1041.
7. Chattopadhyay, R., Conteh, S., Li, M., James, E.R., Epstein, J.E., and Hoffman, S.L. (2009). The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine. Vaccine 27, 3675-3680.
8. Clyde, D.F. (1975). Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24, 397-401.
9. Cockburn, I.A., Chen, Y.C., Overstreet, M.G., Lees, J.R., van Rooijen, N., Farber, D.L., and Zavala, F. (2010). Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog. 6, e1000877.
10. Cohen, J., Benns, S., Vekemans, J., and Leach, A. (2010). The malaria vaccine candidate RTS,S/AS is in phase III clinical trials. Ann. Pharm. Fr. 68, 370-379.
11. Crompton, P.D., Pierce, S.K., and Miller, L.H. (2010). Advances and challenges in malaria vaccine development. J. Clin. Invest. 120, 4168-4178.
12. Doolan, D.L., and Hoffman, S.L. (2000). The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453-1462. (Pubitemid 30604578)
13. Douradinha, B., van Dijk, M.R., Ataide, R., van Gemert, G.J., Thompson, J., Franetich, J.F., Mazier, D., Luty, A.J., Sauerwein, R., Janse, C.J., et al. (2007). Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int. J. Parasitol. 37, 1511-1519.
14. Draper, S.J., Goodman, A.L., Biswas, S., Forbes, E.K., Moore, A.C., Gilbert, S.C., and Hill, A.V. (2009). Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria. Cell Host Microbe 5, 95-105.
15. Good, M.F. (2001). Towards a blood-stage vaccine for malaria: are we following all the leads? Nat. Rev. Immunol. 1, 117-125.
16. Good, M.F., and Doolan, D.L. (2010). Malaria vaccine design: immunological considerations. Immunity 33, 555-566.
17. Greenwood, B. (2011). Immunological correlates of protection for the RTS,S candidate malaria vaccine. Lancet Infect. Dis. 11, 75-76.
18. Grüner, A.C., Brahimi, K., Eling, W., Konings, R., Meis, J., Aikawa, M., Daubersies, P., Guérin-Marchand, C., Mellouk, S., Snounou, G., and Druilhe, P. (2001a). The Plasmodium falciparum knob-associated PfEMP3 antigen is also expressed at pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion. Mol. Biochem. Parasitol. 112, 253-261.
19. Grüner, A.C., Brahimi, K., Letourneur, F., Rénia, L., Eling, W., Snounou, G., and Druilhe, P. (2001b). Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J. Infect. Dis. 184, 892-897.
20. Hafalla, J.C., Cockburn, I.A., and Zavala, F. (2006). Protective and pathogenic roles of CD8+ T cells during malaria infection. Parasite Immunol. 28, 15-24.
21. Hill, A.V., Reyes-Sandoval, A., O'Hara, G., Ewer, K., Lawrie, A., Goodman, A., Nicosia, A., Folgori, A., Colloca, S., Cortese, R., et al. (2010). Prime-boost vectored malaria vaccines: progress and prospects. Hum. Vaccin. 6, 78-83.
22. Hoffman, S.L., Goh, L.M., Luke, T.C., Schneider, I., Le, T.P., Doolan, D.L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., et al. (2002). Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155-1164.
23. Imai, T., Shen, J., Chou, B., Duan, X., Tu, L., Tetsutani, K., Moriya, C., Ishida, H., Hamano, S., Shimokawa, C., et al. (2010). Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain. Eur. J. Immunol. 40, 1053-1061.
24. Jobe, O., Lumsden, J., Mueller, A.K., Williams, J., Silva-Rivera, H., Kappe, S.H., Schwenk, R.J., Matuschewski, K., and Krzych, U. (2007). Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J. Infect. Dis. 196, 599-607.
25. Kaech, S.M., Hemby, S., Kersh, E., and Ahmed, R. (2002). Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837-851. (Pubitemid 36106405)
26. Kappe, S.H., Vaughan, A.M., Boddey, J.A., and Cowman, A.F. (2010). That was then but this is now: malaria research in the time of an eradication agenda. Science 328, 862-866.
27. Kramer, L.D., and Vanderberg, J.P. (1975). Intramuscular immunization of mice with irradiated Plasmodium berghei sporozoites. Enhancement of protection with albumin. Am. J. Trop. Med. Hyg. 24, 913-916.
28. Krzych, U., and Schwenk, J. (2005). The dissection of CD8 T cells during liverstage infection. Curr. Top. Microbiol. Immunol. 297, 1-24.
29. Kumar, K.A., Baxter, P., Tarun, A.S., Kappe, S.H., and Nussenzweig, V. (2009). Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS ONE 4, e4480.
30. Labaied, M., Harupa, A., Dumpit, R.F., Coppens, I., Mikolajczak, S.A., and Kappe, S.H. (2007). Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect. Immun. 75, 3758-3768.
31. Ménard, R., Heussler, V., Yuda, M., and Nussenzweig, V. (2008). Plasmodium pre-erythrocytic stages: what's new? Trends Parasitol. 24, 564-569.
32. Mueller, A.K., Camargo, N., Kaiser, K., Andorfer, C., Frevert, U., Matuschewski, K., and Kappe, S.H. (2005a). Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. USA 102, 3022-3027.
33. Mueller, A.K., Labaied, M., Kappe, S.H., and Matuschewski, K. (2005b). Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433, 164-167.
34. Nussenzweig, R.S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216, 160-162.
35. Overstreet, M.G., Cockburn, I.A., Chen, Y.C., and Zavala, F. (2008). Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol. Rev. 225, 272-283.
36. Pei, Y., Tarun, A.S., Vaughan, A.M., Herman, R.W., Soliman, J.M., Erickson- Wayman, A., and Kappe, S.H. (2010). Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol. Microbiol. 75, 957-971.
37. Preiser, P., Rénia, L., Singh, N., Balu, B., Jarra, W., Voza, T., Kaneko, O., Blair, P., Torii, M., Landau, I., and Adams, J.H. (2004). Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro. Infect. Immun. 72, 3604-3608.
38. Purcell, L.A., Wong, K.A., Yanow, S.K., Lee, M., Spithill, T.W., and Rodriguez, A. (2008). Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 26, 4880-4884.
39. Rai, D., Pham, N.L., Harty, J.T., and Badovinac, V.P. (2009). Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183, 7672-7681.
40. Rénia, L., Ling, I.T., Marussig, M., Miltgen, F., Holder, A.A., and Mazier, D. (1997). Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect. Immun. 65, 4419-4423.
41. Robson, K.J., Hall, J.R., Jennings, M.W., Harris, T.J., Marsh, K., Newbold, C.I., Tate, V.E., and Weatherall, D.J. (1988). A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335, 79-82.
42. Schmidt, N.W., Butler, N.S., Badovinac, V.P., and Harty, J.T. (2010). Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6, e1000998.
43. Sedegah, M., Weiss, W.W., and Hoffman, S.L. (2007). Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol. 29, 559-565. (Pubitemid 47609632)
44. Silvie, O., Franetich, J.F., Charrin, S., Mueller, M.S., Siau, A., Bodescot, M., Rubinstein, E., Hannoun, L., Charoenvit, Y., Kocken, C.H., et al. (2004). A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279, 9490-9496.
45. Speake, C., and Duffy, P.E. (2009). Antigens for pre-erythrocytic malaria vaccines: building on success. Parasite Immunol. 31, 539-546.
46. Szarfman, A., Lyon, J.A., Walliker, D., Quakyi, I., Howard, R.J., Sun, S., Ballou, W.R., Esser, K., London, W.T., Wirtz, R.A., et al. (1988). Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol. 10, 339-351.
47. Tarun, A.S., Dumpit, R.F., Camargo, N., Labaied, M., Liu, P., Takagi, A., Wang, R., and Kappe, S.H. (2007). Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J. Infect. Dis. 196, 608-616.
48. Tarun, A.S., Peng, X., Dumpit, R.F., Ogata, Y., Silva-Rivera, H., Camargo, N., Daly, T.M., Bergman, L.W., and Kappe, S.H. (2008). A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. USA 105, 305-310.
49. Taylor-Robinson, A.W. (2010). Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design. Exp. Parasitol. 126, 406-414.
50. Tsuji, M. (2010). A retrospective evaluation of the role of T cells in the development of malaria vaccine. Exp. Parasitol. 126, 421-425.
51. van Dijk, M.R., Douradinha, B., Franke-Fayard, B., Heussler, V., van Dooren, M.W., van Schaijk, B., van Gemert, G.J., Sauerwein, R.W., Mota, M.M., Waters, A.P., and Janse, C.J. (2005). Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl. Acad. Sci. USA 102, 12194-12199.
52. VanBuskirk, K.M., O'Neill, M.T., De La Vega, P., Maier, A.G., Krzych, U., Williams, J., Dowler, M.G., Sacci, J.B., Jr., Kangwanrangsan, N., Tsuboi, T., et al. (2009). Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc. Natl. Acad. Sci. USA 106, 13004-13009.
53. Vaughan, A.M., O'Neill, M.T., Tarun, A.S., Camargo, N., Phuong, T.M., Aly, A.S., Cowman, A.F., and Kappe, S.H. (2009). Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell. Microbiol. 11, 506-520.
54. Voza, T., Kebaier, C., and Vanderberg, J.P. (2010). Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity. Malar. J. 9, 362.
55. Weiss, W.R., Berzofsky, J.A., Houghten, R.A., Sedegah, M., Hollindale, M., and Hoffman, S.L. (1992). A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J. Immunol. 149, 2103-2109.
56. World Health Organization (WHO). (2010). World malaria report 2010. (http://www.who.int/malaria/world-malaria-report-2010/en/index.html).